Last $102.20 USD
Change Today +0.01 / 0.01%
Volume 5.2M
JNJ On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
Sao Paulo
Bogota
As of 8:04 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joaquin Duato

Worldwide Chairman of Pharmaceuticals, Johnson & Johnson
AgeTotal Calculated CompensationThis person is connected to 34 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mr. Joaquin Duato has been Worldwide Chairman of Pharmaceuticals at Johnson & Johnson since January 3, 2011. Mr. Duato served as Group Chairman of Johnson & Johnson until January 3, 2011. He serves as a Trustee of Save The Children Federation, Incorporated.

Corporate Headquarters*

One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933

United States

Phone: 732-524-0400
Fax: --

Board Members Memberships*

Trustee and Member of Audit Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:US $102.20 USD +0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brian M. Krzanich Chief Executive Officer, Director, Member of Executive Committee and Member of Compensation Committee
Intel Corporation
$887.5K
Alan George Lafley Chairman of the Board, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$1.8M
Virginia M. Rometty Chairman, Chief Executive Officer, President and Chairman of Executive Committee
International Business Machines Corporation
$1.5M
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
$8.5M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.